• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病控制与预防中心免疫实践咨询委员会关于水痘疫苗的建议综述。

Review of recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on varicella vaccine.

作者信息

Holmes S J

机构信息

Center for Pediatric Research, Children's Hospital of the King's Daughters, Eastern Virginia Medical School, Norfolk, USA.

出版信息

J Infect Dis. 1996 Nov;174 Suppl 3:S342-4. doi: 10.1093/infdis/174.supplement_3.s342.

DOI:10.1093/infdis/174.supplement_3.s342
PMID:8896543
Abstract

After US licensure of the Merck varicella vaccine for immunocompetent persons on 17 March 1995, the Advisory Committee on Immunization Practices finalized draft recommendations for varicella prevention in the public health sector. These recommendations call for routine vaccination of children at age 12-18 months with a single dose of the vaccine. Varicella vaccine preferably should be given to children at the same time they receive measles-mumps-rubella vaccine and may be given at the same time as other vaccines recommended at this age. Children ages 18 months to 12 years who have not been vaccinated as part of the routine schedule and who lack a reliable history of varicella should be vaccinated. Vaccination is desirable for persons > or = 13 years old without a reliable history of varicella. Special efforts should be made to assess the immunity of and to vaccinate susceptible persons who have close contact with persons at high risk for complications, including family contacts of immunocompromised individuals and health care workers.

摘要

1995年3月17日默克水痘疫苗在美国获得免疫功能正常人群的许可后,免疫实践咨询委员会最终确定了公共卫生部门预防水痘的建议草案。这些建议要求对12至18个月大的儿童常规接种一剂该疫苗。水痘疫苗最好在儿童接种麻疹-腮腺炎-风疹疫苗的同时接种,也可与该年龄段推荐的其他疫苗同时接种。18个月至12岁未按常规程序接种且无可靠水痘病史的儿童应接种疫苗。13岁及以上无可靠水痘病史的人群也建议接种。应特别努力评估与并发症高危人群密切接触的易感人群的免疫力并为其接种疫苗,包括免疫功能低下个体的家庭接触者和医护人员。

相似文献

1
Review of recommendations of the Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention, on varicella vaccine.疾病控制与预防中心免疫实践咨询委员会关于水痘疫苗的建议综述。
J Infect Dis. 1996 Nov;174 Suppl 3:S342-4. doi: 10.1093/infdis/174.supplement_3.s342.
2
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).水痘预防:免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40.
3
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).使用麻疹、腮腺炎、风疹和水痘联合疫苗:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.
4
Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.水痘的预防:儿童使用水痘疫苗的建议,包括常规2剂水痘免疫接种程序的建议。
Pediatrics. 2007 Jul;120(1):221-31. doi: 10.1542/peds.2007-1089.
5
Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).预防麻疹、风疹、先天性风疹综合征和流行性腮腺炎,2013 年:免疫实践咨询委员会(ACIP)的总结建议。
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.
6
Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.麻疹-腮腺炎-风疹-水痘疫苗1剂次和2剂次接种方案的水痘免疫原性
J Infect Dis. 2008 Mar 1;197 Suppl 2:S152-5. doi: 10.1086/522126.
7
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?一剂水痘疫苗无法预防学校爆发疫情:是时候接种第二剂了吗?
Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085.
8
Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.政策声明——水痘预防:更新儿童使用四价和单价水痘疫苗的建议。
Pediatrics. 2011 Sep;128(3):630-2. doi: 10.1542/peds.2011-1968. Epub 2011 Aug 28.
9
Perspective on live varicella vaccine.对水痘减毒活疫苗的看法。
J Infect Dis. 2008 Mar 1;197 Suppl 2:S242-5. doi: 10.1086/522151.
10
Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP).水痘的预防。免疫实践咨询委员会(ACIP)的更新建议。
MMWR Recomm Rep. 1999 May 28;48(RR-6):1-5.

引用本文的文献

1
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological Perspective.人类α疱疹病毒感染(单纯疱疹病毒1型、单纯疱疹病毒2型和水痘-带状疱疹病毒)、阿尔茨海默病以及靶向治疗或疫苗接种的潜在益处——病毒学视角
Vaccines (Basel). 2025 May 27;13(6):572. doi: 10.3390/vaccines13060572.
2
Efficacy of varicella (VZV) vaccination: an update for the clinician.水痘(VZV)疫苗的疗效:给临床医生的最新信息
Ther Adv Vaccines. 2016 Jan;4(1-2):20-31. doi: 10.1177/2051013616655980. Epub 2016 Jan 1.
3
Varicella susceptibility in a Canadian population.
加拿大人群中水痘易感性
Can J Infect Dis. 2000 Sep;11(5):249-53. doi: 10.1155/2000/243163.
4
Reactogenicity to a live attenuated varicella vaccine in Canadian children.加拿大儿童对减毒活水痘疫苗的反应原性。
Can J Infect Dis. 2000 Mar;11(2):97-101. doi: 10.1155/2000/647245.
5
Varicella vaccination in children with lymphoma and solid tumours.淋巴瘤和实体瘤患儿的水痘疫苗接种
Postgrad Med J. 2006 Nov;82(973):760-2. doi: 10.1136/pmj.2005.041293.
6
Modern veterinary vaccines and the Shaman's apprentice.现代兽用疫苗与巫医的学徒
Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):389-400. doi: 10.1016/S0147-9571(03)00022-5.
7
Necrotizing fasciitis secondary to chickenpox infection in children.儿童水痘感染继发坏死性筋膜炎
Can J Surg. 2003 Feb;46(1):9-14.
8
Vaccination to prevent varicella and shingles.预防水痘和带状疱疹的疫苗接种。
J Clin Pathol. 2001 Oct;54(10):743-7. doi: 10.1136/jcp.54.10.743.
9
Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.比利时医护人员感染水痘带状疱疹病毒的职业风险:一项血清流行率研究。
Occup Environ Med. 2000 Sep;57(9):621-6. doi: 10.1136/oem.57.9.621.
10
Canine viral vaccines at a turning point--a personal perspective.犬类病毒疫苗正处于转折点——个人观点。
Adv Vet Med. 1999;41:289-307. doi: 10.1016/s0065-3519(99)80022-6.